Skip to content

A Self-efficacy Enhancing Stroke Self-management Program for Community-dwelling Stroke Survivors

A Randomized Controlled Trial of the Effectiveness of a Nurse-led Self-efficacy Enhancing Stroke Self-management Program for Community-dwelling Stroke Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02112955
Acronym
SESSMP
Enrollment
128
Registered
2014-04-14
Start date
2014-05-31
Completion date
2016-05-31
Last updated
2016-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Disease management, Self efficacy, Quality of life, Community integration

Brief summary

The aim of this study is to examine the effectiveness of a nurse-led self-efficacy enhancing stroke self-management program on recovery of community-dwelling stroke survivors.

Detailed description

Previous systematic reviews showed that theory-based stroke self-management programs had potential benefits in improving stroke survivors' quality of life and self-efficacy. However there is a lack of evidence evaluating the effectiveness of a nurse-led theory-based stroke self-management program among community-dwelling Chinese stroke survivors. This is a parallel group, single-blinded, randomized controlled trial to be held in a community center. All participants will be assessed at two time-points (baseline before randomization, and one month after program completion). Eligible participants will be randomly allocated to either the control group (receiving usual care) or the intervention group (receiving the self-efficacy enhancing stroke self-management program). Participants in the intervention group will receive an additional assessment on usefulness of the program immediately after program completion.

Interventions

BEHAVIORALStroke self-management program

A nurse-led community-based self-efficacy enhancing stroke self-management program.

BEHAVIORALUsual care

Usual care such as hospital-based or community-based health education or services.

Sponsors

Queensland University of Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 18 years or above * have a clinical diagnosis of stroke * currently live at home or will be discharged from hospital to home within one week * have a Mini Mental State Examination score \>18 * speak Cantonese * capable of giving informed consent * can attend sessions of the self-efficacy enhancing stroke self-management program * can use a phone

Exclusion criteria

* diagnosed with transient ischemic attack, subdural or epidural hemorrhage * have cerebrovascular events due to presence of malignancy or head trauma * have limited comprehension and receptive aphasia * have been diagnosed with schizophrenia, bipolar disorder, or dementia * have received a stroke self-management program in the past 12 months as reported by the participants

Design outcomes

Primary

MeasureTime frameDescription
Self-efficacy in performing stroke self-management behaviorsOne month after the programStroke Self-Efficacy Questionnaire

Secondary

MeasureTime frameDescription
Health-related quality of lifeOne month after the programStroke Specific Quality of Life Scale
Depressive symptomsOne month after the programGeriatric Depression Scale
Stroke self-management behaviorsOne month after the programStroke Self-management Behaviors Performance Scale
Outcome expectationOne month after the programStroke Self-management Outcome Expectation Scale
Community reintegrationOne month after the programReintegration to Normal Living Index

Other

MeasureTime frameDescription
Usefulness of the programWithin one week after the completion of the programExtent of overall program participation, and other qualitative comments.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026